Inicio>>Signaling Pathways>> Cell Cycle/Checkpoint>> Microtubule/Tubulin>>Taccalonolide B

Taccalonolide B

Catalog No.GC37717

Taccalonolide B es un estabilizador de microtÚbulos aislado de Tacca plantaginea, con actividad antitumoral. Taccalonolide B es eficaz in vitro contra las lÍneas celulares que sobreexpresan la glicoproteÍna P (Pgp) y la proteÍna de resistencia a mÚltiples fÁrmacos (MRP7). Taccalonolide B inhibe el crecimiento de las células SK-OV-3 con una IC50 de 208 nM.

Products are for research use only. Not for human use. We do not sell to patients.

Taccalonolide B Chemical Structure

Cas No.: 108885-69-4

Tamaño Precio Disponibilidad Cantidad
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Taccalonolide B is microtubule stabilizer isolated from Tacca plantaginea, with antitumor activity. Taccalonolide B is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug-resistance protein (MRP7). Taccalonolide B inhibits growth of SK-OV-3 cells with an IC50 of 208 nM[1][2]. microtubule[2]

[1]. LiangChen Zhong, et al. Steroidal bitter principles from tacca plantaginea structures of taccalonolide A and B. Tetrahedron Letters. 1987, 28(15): 1673-1675. [2]. Risinger AL, et al. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms. Cancer Res. 2008 Nov 1;68(21):8881-8.

Reseñas

Review for Taccalonolide B

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Taccalonolide B

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.